Although cancer of the testis was one of the most common forms of malignancy in men aged 15-34 between 1989 and 1998, it accounted for less than 2% of all male cancers.Due to improvements in treatment, with dose intensification and the development of new drugs, the outlook should improve for the small proportion of patients with poor prognostic disease, although this will not have a huge effect overall on this disease as the results are already very good.Therefore, although the incidence is rising in most countries in the western world (there are many...